at Aitken Klee LLP
Scott Beeser is a partner in Aitken Klee’s Toronto office with deep experience and a proven track record in litigation under the Patented Medicines (Notice of Compliance) (PM (NOC)) Regulations, representing pharmaceutical clients in the Federal Court, the Federal Court of Appeal and the Supreme Court of Canada.
He has represented both generic and branded pharmaceutical companies. He successfully represented a client in a seminal case that clarified the proper approach for assessing obviousness in Canada. He also successfully represented a client in a matter that redefined which types of claims need to be addressed under the then existing PM (NOC) Regulations. More recently, Mr Beeser successfully represented two generic manufacturers in the first ‘common issues’ validity trial under the new PM (NOC) Regulations and was counsel in the first decision considering whether litigation under these regulations is limited by the initial allegations made by the generic pharmaceutical company.
He also has experience representing patentees in the information technology, medical device and transportation sectors.
Mr Beeser frequently speaks at national conferences on patent issues related to pharmaceutical and biosimilar patent law. He is a regular contributor to Aitken Klee’s blog covering recent developments in IP law.
Mr Beeser has a doctoral degree in biology and is a registered Canadian patent and trademark agent.
Sample client list
- Paid Search Engine Tools
- Taro Pharmaceuticals
- Teva Canada
Aitken Klee LLP
36 Lombard Street
Toronto ON M5C 2X3
See firm profile